micro-community-banner
 
  • Saved
Highlights from the 2022 American Headache Society Annual Scientific Meeting

The first day of the 2022 American Headache Society (AHS) Annual Scientific Meeting kicked off in Denver delivering interesting data and discussions. Click on the image above to view highlights from our team of analysts.

  • Saved
Highlights from the 2022 American Headache Society Annual Scientific Meeting

The first day of the 2022 American Headache Society (AHS) Annual Scientific Meeting kicked off in Denver delivering interesting data and discussions. Click on the image above to view highlights from our team of analysts.


  • Saved
Highlights from the 2022 American Headache Society Annual Scientific Meeting

The first day of the 2022 American Headache Society (AHS) Annual Scientific Meeting kicked off in Denver delivering interesting data and discussions. Click on the image above to view highlights from our team of analysts.


  • Saved
Cerebrovascular reactivity and deep white matter hyperintensities in migraine: A prospective CO 2 targeting study - PubMed

Cerebrovascular reactivity and deep white matter hyperintensities in migraine: A prospective CO 2 targeting study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35607990/

Several studies suggested the association of migraine with deep white matter hyperintensities (WMHs). We aimed to explore the cerebrovascular reactivity (CVR), deep WMH burden, and their association in patients with...


Relevance: Several studies suggested the association of migraine with deep white matter hyperintensities (WMHs). We aimed to explore the cerebrovascular reactivity (CVR), deep WMH burden, and their association in patients with migraine using a state-of-the-art methodology.

  • Saved
Efficacy of ultrasound-guided greater occipital nerve pulsed radiofrequency therapy in chronic refractory migraine - PubMed

Efficacy of ultrasound-guided greater occipital nerve pulsed radiofrequency therapy in chronic refractory migraine - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35650419/

In this study, we observed that US-guided GON PRF therapy applied at the proximal (C2) level was a safe and effective treatment option. With GON PRF, we observed a decrease...



Conclusion: In this study, we observed that US-guided GON PRF therapy applied at the proximal (C2) level was a safe and effective treatment option. With GON PRF, we observed a decrease in pain intensity, pain frequency, and duration of episodes, and an improvement in depression symptoms, migraine disability, and sleep disorder scores...